Project Number 1R44AG071137-01A1 Agency/Funding Organization NIA Funding Year 2021 View Full Project Details for Development of Nav1.1 Enhancers to Treat Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) m. Synaptic Plasticity/Neuroprotection Researcher and Organization Principal Investigator PLEISS, MICHAEL Principal Investigator First Name MICHAEL Principal Investigator Last Name PLEISS Awardee Organization CURE NETWORK DOLBY ACCELERATION PARTNERS LLC Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-19-316: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) FY Overall Cost $449,821 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
